[Pharmacokinetics of bis-phenyl-(2-chloro-phenyl)-1-imidazolyl-methane-( 14 C) following topical administration].
D000328:Adult; D000935:Antifungal Agents / Q000378:metabolism*; D002247:Carbon Isotopes; D004304:Dosage Forms; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000652:urine; D008297:Male; D008697:Methane; D008875:Middle Aged; D009824:Ointments; D012867:Skin / Q000378:metabolism; D012869:Skin Absorption; D012996:Solutions; D013488:Suppositories; D014621:Vagina / Q000378:metabolism
D000935:Antifungal Agents; D002247:Carbon Isotopes; D004304:Dosage Forms; D007093:Imidazoles; D009824:Ointments; D012996:Solutions; D013488:Suppositories; D008697:Methane
Pharmakokinetik nach topischer Anwendung von Bisphenyl-(2-chlorphenyl)-1-imidazolyl-methan-( 14 C.